$60M exit package for S-P CEO Hassan?

Deal-maker par excellence Fred Hassan, chief executive of Schering-Plough, looks likely to get an exit package of around $60.0  million as a result of selling the company to Merck & Co for $41.4  billion (see page 3), according to a report by Bloomberg. Among his past  accomplishments, Mr Hassan has rescued a floundering Upjohn & Pharmacia  - acquiring Monsanto for $37.0 billion in the process, and the group was  later sold to drug giant Pfizer for $59.8 billion. He then joined S-P,  reviving the company's fortunes, including acquiring the Dutch  biotechnology business Organon.